Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eyal Attar
Cancer and Leukemia Group B
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lombardi Comprehensive Cancer Center at Georgetown University
Washington D.C., District of Columbia, United States
- Washington Hospital Center
Washington D.C., District of Columbia, United States
- Florida Hospital
Orlando, Florida, United States
- University of Chicago
Chicago, Illinois, United States
- Eastern Maine Medical Center
Bangor, Maine, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- University of Missouri - Ellis Fischel
Columbia, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- North Shore University Hospital
Manhasset, New York, United States
- North Shore-Lij Health System Ccop
Manhasset, New York, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- North Shore-Lij Health System/center for Advanced Medicine
New Hyde Park, New York, United States
- Mount Sinai Medical Center
New York, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Kinston Medical Specialists Pa
Kinston, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2008
- Primary completion
- 31 Jul 2010
- Completion
- 31 Dec 2012
- Last update posted
- 12 Sept 2014
- Registered enrollment
- 95
- Registry id
- NCT00742625
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.